Back
Armata Pharmaceuticals Stock Price Chart

This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
63
ARMP
Armata Pharmaceuticals
Last Price:
$2.31
Seasonality Move:
12.64%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ARMP is experiencing buying pressure, which is a positive indicator for future bullish movement.
Armata Pharmaceuticals Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.48 | Buy |
20-day SMA: | 1.44 | Buy |
50-day SMA: | 1.5 | Buy |
200-day SMA: | 2.06 | Buy |
8-day EMA: | 1.59 | Buy |
20-day EMA: | 1.47 | Buy |
50-day EMA: | 1.53 | Buy |
200-day EMA: | 2 | Buy |
Armata Pharmaceuticals Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.06 | Buy |
Relative Strength Index (14 RSI): | 76.26 | Buy |
Chaikin Money Flow: | 6407373 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.16 - 1.62) | Buy |
Bollinger Bands (100): | (1.41 - 2.13) | Buy |
Armata Pharmaceuticals Technical Analysis
May 6 | May 7 | May 8 | May 9 | May 12 | May 13 | May 14 | May 15 | May 16 | May 19 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
06 | 07 | 08 | 09 | 12 | 13 | 14 | 15 | 16 | 19 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Armata Pharmaceuticals Stock
Is Armata Pharmaceuticals Stock a Buy?
-
Armata Pharmaceuticals share price is 2.37 while ARMP 8-day simple moving average is 1.48, which is a Buy signal.
-
The stock price of ARMP is 2.37 while Armata Pharmaceuticals 20-day SMA is 1.44, which makes it a Buy.
-
Armata Pharmaceuticals 50-day simple moving average is 1.50 while ARMP share price is 2.37, making it a Buy technically.
-
ARMP stock price is 2.37 and Armata Pharmaceuticals 200-day simple moving average is 2.06, creating a Buy signal.
ARMP Technical Analysis vs Fundamental Analysis
Buy
63
Armata Pharmaceuticals (ARMP)
is a Buy
Is Armata Pharmaceuticals a Buy or a Sell?
-
Armata Pharmaceuticals stock is rated a BuyThe current Armata Pharmaceuticals [ARMP] share price is $2.37. The Score for ARMP is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
Armata Pharmaceuticals Stock Info
Market Cap:
85.8M
Price in USD:
2.37
Share Volume:
11.1M
Armata Pharmaceuticals 52-Week Range
52-Week High:
3.42
52-Week Low:
0.90
Buy
63
Armata Pharmaceuticals (ARMP)
is a Buy
Armata Pharmaceuticals Share Price Forecast
-
What is the Armata Pharmaceuticals stock price today?The Armata Pharmaceuticals stock price is 2.37 USD today.
-
Will ARMP stock go up or go down?Armata Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators
-
Is Armata Pharmaceuticals overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Armata Pharmaceuticals is not overvalued.
Is Armata Pharmaceuticals Stock a Buy?
-
Armata Pharmaceuticals share price is 2.37 while ARMP 8-day exponential moving average is 1.59, which is a Buy signal.
-
The stock price of ARMP is 2.37 while Armata Pharmaceuticals 20-day EMA is 1.47, which makes it a Buy.
-
Armata Pharmaceuticals 50-day exponential moving average is 1.53 while ARMP share price is 2.37, making it a Buy technically.
-
ARMP stock price is 2.37 and Armata Pharmaceuticals 200-day simple moving average is 2.00, creating a Buy signal.
Fundamental Analysis of Armata Pharmaceuticals
Is Armata Pharmaceuticals a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.14 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.99 per share, and a decrease next year of $0.00 per share.
Technical Analysis of Armata Pharmaceuticals
Should I short Armata Pharmaceuticals stock?
-
ARMP Moving Average Covergence Divergence (MACD) indicator is 0.06, suggesting Armata Pharmaceuticals is a Buy
-
Armata Pharmaceuticals Relative Strength Index (RSI) is 76.26, which suggest Armata Pharmaceuticals is overbought
-
The Bollinger Bands (25) for Armata Pharmaceuticals is (1.16 - 1.62), which suggest Armata Pharmaceuticals is a Buy
-
The Bollinger Bands (100) for Armata Pharmaceuticals is (1.41 - 2.13), which suggest Armata Pharmaceuticals is a Buy
* Armata Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.